University of Michigan at Ann Arbor

Organization

People

Sources: reporter.nih.gov

Grants and prizes

  • National Eye Institute

    R56, Inflammatory mechanisms that regulate neuronal regeneration, R56EY037725, $1.2M, 2026–2028, Sep 19, 2026

  • National Institute on Drug Abuse

    R01, Biological Aging Across the Lifespan in the Monitoring the Future Longitudinal Panel Study, R01DA016575, $1.1M, 2026–2027, Sep 18, 2026

  • National Eye Institute

    R01, Biobank phenotyping tools for improved understanding and management of eye diseases and disparities, R01EY036473, $438K, 2026–2029, Sep 17, 2026

  • National Institute on Deafness and Other Communication Disorders

    R21, Drug Selection and Direct Reprogramming in Generation and Culture of Otic Progenitors, R21DC023396, $429K, 2026–2028, Sep 17, 2026

  • National Cancer Institute

    U54, Center for the Assessment of Tobacco Regulations (CAsToR) TCORS 3.0, U54CA229974, $4.1M, 2018–2028, Sep 17, 2026

  • National Institute of Nursing Research

    R01, PROSPERing: Integrating Exercise into Routine HIV Care to Manage Symptoms and Promote Healthy Aging, R01NR022022, $816K, 2026–2031, Sep 17, 2026

  • National Cancer Institute

    R01, Advancing the Use of the Kettles Esophageal and Cardia Adenocarcinoma Prediction Tool, R01CA295896, $544K, 2026–2031, Sep 17, 2026

  • National Institute of Neurological Disorders and Stroke

    R56, Structural interrogation of TDP43 mislocalization and aggregation in aging and disease, R56NS147344, $555K, 2026–2027, Sep 14, 2026

  • National Institute of Neurological Disorders and Stroke

    R37, Brain Attack Surveillance in Corpus Christi (BASIC) Project, R37NS038916, $1.4M, 1999–2028, Sep 14, 2026

  • National Heart, Lung, and Blood Institute

    K23, Implementation research for comprehensive cardiometabolic care in Guatemala, K23HL161271, $157K, 2022–2027, Sep 11, 2026

  • National Heart, Lung, and Blood Institute

    R01, Leveraging Quantitative Imaging from Lung Cancer Screening to Create Tools to Confront COPD, R01HL174648, $657K, 2024–2028, Sep 8, 2026

  • National Institute on Aging

    R01, Predictors of transitions to cognitive impairment and dementia across the cognitive status trajectory, R01AG100051, $568K, 2026–2031, Sep 8, 2026

  • National Cancer Institute

    R01, Smokeless Tobacco Cessation in Odisha, India: A Randomized Control Trial in Primary Care Clinics, R01CA309440, $475K, 2026–2031, Sep 7, 2026

  • National Institute on Aging

    R01, The National Neighborhood Data Archive: A Resource to Understand Health Risk & Resilience for Aging in The United States, R01AG109115, $2.1M, 2026–2031, Sep 1, 2026

  • National Institute of Diabetes and Digestive and Kidney Diseases

    R01, Schwann Cell Senescence and the Secretome Provide a Unifying Mechanism for the Onset and Progression of Diabetic Neuropathy, R01DK130913, $779K, 2022–2031, Sep 1, 2026

  • National Institute on Aging

    R01, The Value of Medicaid for Adults Ages 50-64, R01AG104199, $779K, 2026–2031, Sep 1, 2026

  • National Cancer Institute

    P50, Michigan Prostate SPORE 2025-2030, P50CA186786, $2.3M, 2014–2030, Sep 1, 2026

  • National Institute on Aging

    F32, Preparing to optimize a multimodal adaptive intervention for physical activity behavior change among middle age and older adults, F32AG096907, $76.8K, 2025–2027, Sep 1, 2026

  • National Institute on Aging

    U01, The impact of metals and polygenic risk on multiomics, brain aging, and ADRD outcomes, U01AG088407, $1.5M, 2024–2029, Sep 1, 2026

  • National Institute on Aging

    R01, An mHealth intervention to promote physical activity in middle-aged and older adults to reduce the risk of Alzheimer's disease and related dementias: The Move2Joy randomized controlled trial, R01AG093699, $936K, 2026–2031, Sep 1, 2026

Sources: reporter.nih.gov